The story

From the bench to the clinic

The path of Dr. Damon Tojjar, physician-scientist, from diabetes genetics to validated clinical AI. One throughline: rigorous science and well-built technology, in service of the patient.

See the timelineAbout
  • M.D.Lund University
  • StanfordSystems Medicine
  • ScienceMagnus Blix Award
  • EITTop 20 Deep Tech
0+
Citations to co-authored research, Diabetes Care (paper-level)
0+
Cited expert articles and explainers published
0
Peer-reviewed publications (Tojjar, D.)
0
Major awards (Magnus Blix, Medtech4Health, EIT)

Timeline

Milestones, from discovery to deployment.

  1. M.D., Lund University
    Medical training across internal medicine, surgery, psychiatry, and family medicine.
  2. Research Fellow, Systems Medicine, Stanford
    Diabetes genetics and computational biology with Professor Atul Butte. Anna Lindh Fellow.
  3. Diabetologia
    Co-author on gene-discovery work linking CACNA1E (CaV2.3) to type 2 diabetes and impaired insulin secretion.
  4. Science and the Magnus Blix Award
    Shared (co-second) author on the alpha2A-adrenergic receptor study of type 2 diabetes, recognized with the Magnus Blix Award.
  5. Diabetes Care meta-analysis
    Co-author on a systematic review and meta-analysis of ethnic differences in diabetes risk, cited more than 800 times.
  6. Novo Nordisk, Global Development
    International Medical Manager and Principal Medical Specialist on global diabetes programs for GLP-1, insulin, and combination therapies.
  7. EASY Diabetes and the Medtech4Health Award
    Co-developed and led the EASY Diabetes decision-support system; the EASY-1 randomized controlled trial compared the system against standard of care; Medtech4Health Innovation Award.
  8. Vi-Health and EIT Top 20 Deep Tech
    Co-founded Vi-Health, a Top 20 Deep Tech finalist in the EIT Digital Challenge, later acquired by Numan.
  9. Nucleate mentor
    Mentoring early-career scientists building biotech ventures.

About

The short version.

Dr. Damon Tojjar is a physician-scientist and digital health entrepreneur whose work spans global drug development, clinical AI, and medical-device regulation, with research roots in diabetes genetics and metabolic disease. Trained in medicine at Lund University and in systems medicine at Stanford, his diabetes-genetics research includes a shared (co-second) author contribution to a paper in Science, recognized with the Magnus Blix Award, and a Diabetes Care meta-analysis cited more than 800 times. He co-developed EASY Diabetes, an AI decision-support system that won Sweden's Medtech4Health Innovation Award, and co-founded Vi-Health, which was selected as one of 20 finalists (Top 20 Deep Tech) in the EIT Digital Challenge and later acquired by Numan.

Contact

Get in touch.

For collaboration, advisory, speaking, or media, reach out directly.

contact@damontojjar.com